Prevent chemical vapors from escaping from solvent containers Use traps with Luer connection with T-series solvent waste caps without valve and filter. Traps with 1/4"-28 UNF(M) connection works with caps with vent.
Prevent chemical vapors from escaping from solvent containers Use traps with Luer connection with T-series solvent waste caps without valve and filter. Traps with 1/4"-28 UNF(M) connection works with caps with vent.
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even
LTV-1 is a potent lymphoid tyrosine phosphatase ( LYP ) inhibitor in T cells with an IC 50 of 508 nM. LTV-1 has the potential for autoimmunity treatmentIn VitroLTV-1 (1.25-40 μM) has no notable effect on cell viability (metabolic rate assay), even